Denis Delval, CEO of iconic French pharma firm LFB since December 2017, discusses his key priorities to build the new LFB.
My vision is that we should be strong enough to assume a leadership position in any space that we seek to participate in
Denis Delval – CEO, LFB, France
13.02.2019
Denis Delval, CEO of iconic French pharma firm LFB since December 2017, discusses his key priorities to build the new LFB.
Related Interviews
Francois Cornu – President Eurofins Biomnis & Gautier Decock –…
Francois Cornu, president of Eurofins Biomnis, and Gautier Decock, managing director of Eurofins BioPharma Product Testing in France and Belgium, come together to shed light on the company’s unique decentralized…
Nathalie Giraud – Director of Integrated Monitoring Investigator Services…
Nathalie Giraud, director of integrated monitoring investigator services & head of France at PPD, breaks down the strengths and weaknesses of the French clinical trials environment and stresses the importance…
Claire Mounier-Vehier – Cardiologist, Head of Vascular Medicine &…
Speaking exclusively to PharmaBoardroom at the International Women’s Day 2020 event at the Franco-British Chamber of Commerce in Paris, esteemed cardiologist Professor Claire Mounier-Vehier outlines why cardiovascular disease is not…
Top 10 Global Pharma Markets Ranking
Based on IQVIA’s pharma market rankings for 2020, we give a rundown of the global top 10, key companies, important trends, and where you can go to learn more. …
France / Owkin Becomes Unicorn; Sanofi/Baidu Tie-up for mRNA Algorithm; New Deals for Pierre Fabre & Abionyx
The latest news from French pharma, including AI-based biotech Owkin’s new status as a USD one billion-valued unicorn following fresh investment from Sanofi. Also included is another deal for Sanofi,…
Europe / Top 5 Countries for Pharma Production
The Top Five countries in Europe for pharma production. All located in Western Europe, Switzerland punches well above its weight to take top spot. This data is taken from the 2021…
Latest Report
